Ramius Advisors’s PepperLime Health Acquisition Corporation Warrrant PEPLW Stock Holding History

Ramius Advisors’s Portfolio PEPLW Stock Details PEPLW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-93,525	Closed	-$1.43K	–	121
2022 Q4	$1.43K	Sell	93,525 -400	-0.4%	-$12	﹤0.01%	126
2022 Q3	$8K	Hold	93,925	–	–	﹤0.01%	141
2022 Q2	$24K	Buy	+93,925	New	+$38.4K	0.01%	119
2022 Q1	–	Sell	-31,018	Closed	-$14K	–	140
2021 Q4	$14K	Buy	+31,018	New	+$14.6K	﹤0.01%	339

Other funds holding PEPLW

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

ACM

Altium Capital Management New York $68.8M AUM 7.27% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $33.5B AUM 25.57% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Ramius Advisors's PEPLW Position: Q1 2023 in Review

Ramius Advisors sold out of PepperLime Health Acquisition Corporation Warrrant (PEPLW) in Q1 2023, closing a stake of 93,525 shares — an estimated $1.43K sold.

Ramius Advisors first reported a position in PEPLW in Q4 2021 and held it in 4 quarters. The position peaked at $24K in Q2 2022. 23 funds tracked by Wall St. Rank hold PEPLW as of Q1 2023.

Ramius Advisors reported no remaining PepperLime Health Acquisition Corporation Warrrant position as of Q1 2023 after selling out during the quarter.
Ramius Advisors sold 93,525 PepperLime Health Acquisition Corporation Warrrant shares in Q1 2023, an estimated $1.43K.
Ramius Advisors first reported a position in PepperLime Health Acquisition Corporation Warrrant in Q4 2021 and held it in 4 quarters.
Ramius Advisors's PepperLime Health Acquisition Corporation Warrrant position peaked at $24K in Q2 2022.
23 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Warrrant as of Q1 2023.

Based on Ramius Advisors's 13F filing for Q1 2023, filed 11 May 2023.